TIME FOR LIFE

INFLIXIMAB

  • Chimeric monoclonal antibody to selectively block tumor necrosis factor (TNF)
  • Used to treat a wide range of severe autoimmune diseases: rheumatoid and psoriatic arthritis, ankylosing spondylitis, Crohn’s disease (active form), ulcerative colitis and psoriasis
  • The drug is in the process of registration